Literature DB >> 29561910

Correction: Rapid enteric testing to permit targeted antimicrobial therapy, with and without Lactobacillus reuteri probiotics, for paediatric acute diarrhoeal disease in Botswana: A pilot, randomized, factorial, controlled trial.

Jeffrey M Pernica, Andrew P Steenhoff, Margaret Mokomane, Banno Moorad, Kwana Lechiile, Marek Smieja, Loeto Mazhani, Ji Cheng, Matthew S Kelly, Mark Loeb, Ketil Stordal, David M Goldfarb.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0185177.].

Entities:  

Year:  2018        PMID： 29561910      PMCID： PMC5862480          DOI： 10.1371/journal.pone.0194957

Source DB:  PubMed          Journal:  PLoS One        ISSN： 1932-6203            Impact factor:   3.240


The dose of Lactobacillus reuteri DSM 17938 appears incorrectly throughout the article as 5x108 colony-forming units (cfu) per day. The correct dose of of Lactobacillus reuteri DSM 17938 should be 1x108 cfu per day.
  1 in total

1.  Rapid enteric testing to permit targeted antimicrobial therapy, with and without Lactobacillus reuteri probiotics, for paediatric acute diarrhoeal disease in Botswana: A pilot, randomized, factorial, controlled trial.

Authors:  Jeffrey M Pernica; Andrew P Steenhoff; Margaret Mokomane; Banno Moorad; Kwana Lechiile; Marek Smieja; Loeto Mazhani; Ji Cheng; Matthew S Kelly; Mark Loeb; Ketil Stordal; David M Goldfarb
Journal:  PLoS One       Date:  2017-10-09       Impact factor: 3.240
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.